Stoxx Europe 50
|
5 357,10
|
36,43
|
0,68 %
|
Analysen zu Stoxx Europe 50-Werten
| 10.02.25 | Novo Nordisk Buy | UBS AG | |
| 10.02.25 | BAT Buy | UBS AG | |
| 10.02.25 | SAFRAN Outperform | RBC Capital Markets | |
| 10.02.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 10.02.25 | GSK Hold | Deutsche Bank AG | |
| 10.02.25 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 10.02.25 | VINCI Buy | Deutsche Bank AG | |
| 10.02.25 | Intesa Sanpaolo Buy | Goldman Sachs Group Inc. | |
| 10.02.25 | Roche Sell | Goldman Sachs Group Inc. | |
| 10.02.25 | L'Oréal Buy | Goldman Sachs Group Inc. | |
| 10.02.25 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
| 10.02.25 | AB InBev Overweight | JP Morgan Chase & Co. | |
| 10.02.25 | Unilever Sell | UBS AG | |
| 10.02.25 | BP Sector Perform | RBC Capital Markets | |
| 10.02.25 | Rio Tinto Neutral | UBS AG | |
| 10.02.25 | L'Oréal Neutral | UBS AG | |
| 10.02.25 | BP Buy | Jefferies & Company Inc. | |
| 10.02.25 | L'Oréal Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 10.02.25 | Roche Outperform | Bernstein Research | |
| 09.02.25 | BP Buy | Jefferies & Company Inc. | |
| 07.02.25 | ING Group Sector Perform | RBC Capital Markets | |
| 07.02.25 | ASML NV Buy | Jefferies & Company Inc. | |
| 07.02.25 | AstraZeneca Halten | DZ BANK | |
| 07.02.25 | VINCI Overweight | JP Morgan Chase & Co. | |
| 07.02.25 | UBS Halten | DZ BANK | |
| 07.02.25 | ABB Kaufen | DZ BANK | |
| 07.02.25 | Airbus Outperform | RBC Capital Markets | |
| 07.02.25 | BP Sector Perform | RBC Capital Markets | |
| 07.02.25 | GSK Outperform | Bernstein Research | |
| 07.02.25 | Airbus Buy | Jefferies & Company Inc. | |
| 07.02.25 | ING Group Hold | Deutsche Bank AG | |
| 07.02.25 | AstraZeneca Hold | Deutsche Bank AG | |
| 07.02.25 | L'Oréal Sell | Deutsche Bank AG | |
| 07.02.25 | VINCI Buy | Deutsche Bank AG | |
| 07.02.25 | SAP Hold | Warburg Research | |
| 07.02.25 | BP Underweight | JP Morgan Chase & Co. | |
| 07.02.25 | UBS Overweight | JP Morgan Chase & Co. | |
| 07.02.25 | GSK Underweight | JP Morgan Chase & Co. | |
| 07.02.25 | Novo Nordisk Buy | UBS AG | |
| 07.02.25 | GSK Neutral | Goldman Sachs Group Inc. |
HOT STOCKS DER LETZTEN 3 TAGE
Analysen zu Aktien folgender Indizes
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.